chr6-125081449-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001286398.3(RNF217):c.1497C>A(p.Phe499Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000478 in 1,610,978 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001286398.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RNF217 | NM_001286398.3 | c.1497C>A | p.Phe499Leu | missense_variant | 5/6 | ENST00000521654.7 | NP_001273327.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RNF217 | ENST00000521654.7 | c.1497C>A | p.Phe499Leu | missense_variant | 5/6 | 2 | NM_001286398.3 | ENSP00000428698.2 |
Frequencies
GnomAD3 genomes AF: 0.000164 AC: 25AN: 152022Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000561 AC: 14AN: 249718Hom.: 0 AF XY: 0.0000519 AC XY: 7AN XY: 134956
GnomAD4 exome AF: 0.0000350 AC: 51AN: 1458838Hom.: 0 Cov.: 30 AF XY: 0.0000344 AC XY: 25AN XY: 725766
GnomAD4 genome AF: 0.000171 AC: 26AN: 152140Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74380
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 25, 2024 | The c.621C>A (p.F207L) alteration is located in exon 7 (coding exon 5) of the RNF217 gene. This alteration results from a C to A substitution at nucleotide position 621, causing the phenylalanine (F) at amino acid position 207 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at